1. Wintering, Astrid, Hecht, Anna, Meyer, Julia, Loh, Mignon L, Stieglitz, Elliot. 2024. LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia. In Haematologica, 109, 2533-2541. doi:10.3324/haematol.2023.283776. https://pubmed.ncbi.nlm.nih.gov/38152053/
2. Zhang, Yaoyuan, Morris, Rhiannon, Brown, Grant J, Vinuesa, Carola G, Ellyard, Julia I. 2024. Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity. In The Journal of experimental medicine, 221, . doi:10.1084/jem.20221080. https://pubmed.ncbi.nlm.nih.gov/38417019/
3. Dale, Bethany L, Madhur, Meena S. . Linking inflammation and hypertension via LNK/SH2B3. In Current opinion in nephrology and hypertension, 25, 87-93. doi:10.1097/MNH.0000000000000196. https://pubmed.ncbi.nlm.nih.gov/26717315/
4. Beghini, Alessandro, Leuzzi, Livia, Abazari, Nazanin, Trojani, Alessandra, Cairoli, Roberto. 2022. A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms. In Hematological oncology, 40, 1109-1112. doi:10.1002/hon.3023. https://pubmed.ncbi.nlm.nih.gov/35570682/
5. Reshmi, Shalini C, Harvey, Richard C, Roberts, Kathryn G, Gastier-Foster, Julie M, Hunger, Stephen P. 2017. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. In Blood, 129, 3352-3361. doi:10.1182/blood-2016-12-758979. https://pubmed.ncbi.nlm.nih.gov/28408464/
6. Roberts, Kathryn G, Li, Yongjin, Payne-Turner, Debbie, Zhang, Jinghui, Mullighan, Charles G. . Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. In The New England journal of medicine, 371, 1005-15. doi:10.1056/NEJMoa1403088. https://pubmed.ncbi.nlm.nih.gov/25207766/
7. Zhang, Jinghui, Ding, Li, Holmfeldt, Linda, Downing, James R, Mullighan, Charles G. 2012. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. In Nature, 481, 157-63. doi:10.1038/nature10725. https://pubmed.ncbi.nlm.nih.gov/22237106/
8. Blombery, Piers, Pazhakh, Vahid, Albuquerque, Adriana S, Burns, Siobhan O, Lieschke, Graham J. 2023. Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi-organ autoimmunity. In EJHaem, 4, 463-469. doi:10.1002/jha2.698. https://pubmed.ncbi.nlm.nih.gov/37206266/
智鼠故事 
